Arkolith/Insider Trading/AADI/Form 4

Desai Neil

EXECUTIVE CHAIRMAN, DirectorAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Mar 4, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$85K
Net Open-Market Flow
-$85K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2024Sell(S)15K$2.10$31K1.4M
Mar 1, 2024Sell(S)27K$1.97$53K1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-006421) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML